(Q41472821)
Statements
Clinical dose-regimen studies with latanoprost, a new ocular hypotensive PGF2 alpha analogue (English)
M Diestelhorst
G K Krieglstein
M Lusky
S Nagasubramanian
1 February 1997
scientific article published on February 1997
No description defined